Intestinal neoplasms

Sternberg's Diagnostic Surgical Pathology: Fifth Edition

Volumn 2-2, Issue , 2010, Pages 1368-1431

  Cooper, Harry S ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988882827     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (249)

1. O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CPG island methylation phenotype, BRAF and K-ras status in serrated polyps in traditional adenomas indicate separate pathways to distinct colorectal carcinoma endpoint. Am J Surg Pathol 2006;30:1491-1501.
2. Yamamoto T, Konishi K, Yamochi T, et al. No major tumorigenic wall per beta-catenin and serrated as opposed to conventional colorectal adenomas. Br J Cancer 2003;89:152-157.
3. Spring KJ, Zahao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006;131:1400-1407.
4. Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology 2005;47:32-40.
5. Torlakovic E, Skovlund E, Snover DC, et al. Morphological re-assessment of serrated colorectal polyps. Am J Surg Pathol 2003:27:65-81.
6. Farris AB, Misdraji J, Srivastava A, et al. Sessile serrated adenoma. Challenging discrimination from other serrated colonic polyps. Am J Surg Pathol 2008;32:30-35.
7. Burt R, Jass JR. Hyperplastic polyposis. In Hamilton SR, Aaltonen LA, eds. WHO Classification of Tumors, Pathology, and Genetics: Tumors of the Digestive System. Lyon, France: IARC Press, 2000:135-136.
8. Leggett BA, Devereaux B, Biden K, et al. Hyperplastic polyposis associated with colorectal cancer. Am J Surg Pathol 2001;25:177-184.
9. Torlakovic E, Snover DC. Serrated adenomatous polyposis. Gastroenterology 1996;110:748-755.
10. Chao WE, Lipton L, Lynch E, et al. Hyperplastic polyposis. Phenotypic presentations and role of MBD4 and MYH. Gastroenterology 2006;131:30-39.
11. Yantis RK, Goldman H, Odze RD. Hyperplastic polyp with epithelial misplacement (inverted hyperplastic polyp): a clinicopathological and immunohistochemical study of nineteen cases. Mod Pathol 2001;14:869-876.
12. Goldstein NS, Bhanot P, Odish E, et al. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 2003;119;778-796.
13. Snover DC, Jass JR, Fenoglio-Preiser C, et al. Serrated polyps of the large intestine. A morphological and molecular review of an evolving concept. Am J Clin Pathol 2005;124:380-391.
14. Torlakovic EE, Gomez JD, Driman DK, et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 2008;32:21-29.
15. Sheridan TB, Fenton H, Lewin MR, et al. Sessile serrated adenomas with low and high grade dysplasia in early carcinomas. An immunohistochemical study of serrated lesions "caught in the act." Am J Clin Pathol2006;126:564-571.
16. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenoma: a distinctive form of colorectal neoplasia. Am J Surg Pathol 1990;14:524-537.
17. Iino H, Jass JR, Simms LA, et al. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal carcinoma. J Clin Pathol 1999;52:5-9.
18. Jass JR, Cottier DS, Polous V, et al. Mixed epithelial polyps in association with hereditary non-polyposis colorectal cancer providing an alternative pathway of cancer histogenesis. Pathology 1997;29:28-33.
19. Nakayama H, Fuji M, Kimura A, et al. A solitary Peutz-Jeghers type hamartomatous polyp of the rectum: report of a case and review of the literature. J Clin Oncol 1996;26:273-276.
20. Sone Y, Nakano S, Takeda I, et al. Solitary hamartomatous polyp of the Peutz-Jeghers type in the jejunum resected endoscopically. Gastrointest Endosc 2000;51:620-622.
21. Altonen LA, Jarvin NH, Gruber SB. Peutz-Jeghers syndrome. In Hamilton SR, Aaltonen LA, eds. WHO Classification of Tumors, Pathology, and Genetics: Tumors of the Digestive System. Lyon, France: IARC Press, 2000:74-76.
22. Rustgi AK. Hereditary gastrointestinal polyposis and nonpolyposis syndrome. N Engl J Med 1994;331:1694-1702.
23. Giardiello FM, Brensinger JD, Tersmette AC, et al. A very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000;119:1447-1453.
24. Schreibman IR, Baker M, Amos C, et al. The hamartomatous polyposis syndrome: clinical and molecular review. Am J Gastroenterol 2005;100:476-490.
25. Hizawa K, Iida M, Matsumoto T, et al. Cancer in Peutz-Jeghers syndrome. Cancer 1993:72:2777-2781.
26. Burkart AL, Sherrin T, Lewin M, et al. Do sporadic Peutz-Jeghers polyps exist? Experience at a large teaching hospital. Am J Surg Pathol 2007;31:1209-1214.
27. Onccl M, Remzi FH, Church JM, et al. Course and follow-up of solitary Peutz-Jeghers polyps: a case series. Int J Colorectal Dis 2003;18:33-35.
28. Mayaki M, Iijim AT, Hosona K, et al. Somatic mutations of LKB1 and beta catenin genes in gastrointestinal polyps in patients with Peutz-Jeghers syndrome. Cancer Res 2000;60:6311-6313.
29. Heare N, Shumaker V, Menko FH, et al. Frequency on spectrum of cancer in the PeutzJeghers syndrome. Clin Cancer Res 2006;12:3209-3215.
30. Narita T, Eto T, Ito T. Peutz-Jeghers syndrome with adenomas and adenocarcinomas in colonic polyps. Am J Surg Pathol 1987;11:76-81.
31. Hizawa K, Iida M, Matsumoto T, et al. Neoplastic transformation arising in Peutz-Jeghers polyposis. Dis Colon Rectum 1993;36:953-957.
32. Shepherd NA, Bussey HJ, Jass JR. Epithelial misplacement in Peutz-Jeghers polyps: a diagnostic pitfall. Am J Surg Pathol 1987;11:743-749.
33. Patterson MJ, Kernen JA. Epithelioid leiomyosarcoma originating in a hamartomatous polyp from a patient with Peutz-Jeghers syndrome. Gastroenterology 1985;88:1060-1064.
34. Eng C, Talbot IC, Burt R. Cowden syndrome. In Hamilton SR, Aaltonen LA, eds. WHO Classification of Tumors, Pathology, and Genetics: Tumors of the Digestive System. Lyon, France: IARC Press, 2000:132-134.
35. Shekitka KM, Sobin LH. Ganglioneuromas of the gastrointestinal tract: relationship to Von Recklinghausen disease and other multiple tumor syndromes. Am J Surg Pathol 1994;18:250-257.
36. Roth SI, Helwig EB. Juvenile polyps of the colon and rectum. Cancer 1963;16:468-479.
37. Altonen LA, Jass JR, Howe JR. Juvenile polyposis. In Hamilton SR, Aaltonen LA, eds. WHO Classification of Tumors, Pathology, and Genetics: Tumors of the Digestive System. Lyon, France: IARC Press, 2000:130-132.
38. Jass JR, Williams CB, Bussey HJ, et al. Juvenile polyposis: a precancerous condition. Histopathology 1988;13:619-630.
39. Jessurun J, Paplanus SH, Nagle RB, et al. Pseudosarcomatous changes in inflammatory polyps of the colon. Arch Pathol Lab Med 1986;110:833-836.
40. Nugent KP, Talbot IZ, Hodgson SV, et al. Solitary juvenile polyp: not a marker for subsequent malignancy. Gastroenterology 1993;105:698-700.
41. Goodman ZD, Yardley J, Miligan FD. Pathogenesis of colonic polyps in multiple juvenile polyposis: report of a case associated with gastric polyps and carcinoma of the rectum. Cancer 1979;43:1906-1913.
42. Tung-Hua L, Min-Chang C, Hsien-Chiu T, et al. Malignant change of juvenile polyp of the colon: a case report. Chin Med J (Engl) 1978;4:434-439.
43. Wu TT, Rezal B, Rashid A, et al. Genetic alterations and epithelial dysplasia in juvenile polyposis syndromes and sporadic juvenile polyps. Am J Pathol 1997;150:939-997.
44. Mendelsohn G, Diamond MP. Familial ganglioneuromatosis of the large bowel: report of a family with associated juvenile polyposis. Am J Surg Pathol 1984;8:515-520.
45. Shekitka KM, Helwig EB. Deceptive bizarre stromal cells in polyps and ulcers and of the gastrointestinal tract. Cancer 1991;67:2111-2117.
46. Chetty R, Bhathel PS, Slavin JL. Prolapsed induced inflammatory polyps of the colorectum and anal transitional zone. Histopathology 1993;23:63-67.
47. Gehenot M, Colombel JF, Wolschies E, et al. Inflammatory cap polyposis occurring in the post operative course of pelvic surgery. Gut 1994;35:1670-1672.
48. Nakamura SI, Kino I, Akagi T. Inflammatory myoglandular polyps of the colon and rectum: a clinicopathological study of 32 pedunculated polyps distinct from other types of polyps. Am J Surg Pathol 1992;16:772-779.
49. Kelly JK. Polypoid prolapse in mucosal folds in diverticular disease. Am J Surg Pathol 1991;15:871-878.
50. Abrams NA, Vesoulis Z, Petras RE. Angiogenic polypoid proliferation adjacent to ileal carcinoid tumors: a nonspecific finding related to mucosal prolapse. Mod Pathol 2001;14:821-827.
51. Cai YC, Barnard G, Hiestand L, et al. Florid angiogenesis in mucosa surrounding an ileal carcinoid tumor expressing transforming growth factor alpha. Am J Surg Pathol 1997;21:1373-1377.
52. Shimer GR, Helwig EB. Inflammatory fibroid polyps of the intestine. Am J Clin Pathol 1984;81:708-714.
53. Daniel ES, Ludwig SL, Lewin KJ, et al. The Cronkite-Canada syndrome: an analysis of clinical and pathological features and therapy in 55 patients. Medicine (Baltimore) 1982;61:293-309.
54. Katayama Y, Kimura M, Konn M. Cronkite-Canada syndrome associated with rectal cancer and adenomatous changes in colonic polyps. Am J Surg Pathol 1985;9:65-71.
55. Corres JS, Wallace MH, Morson BC. Benign lymphomas of the rectum and anal canal: a study of 100 cases. J Pathol Bacteriol 1961;82:371-382.
56. Venkitachalam PS, Hirsch E, Elguezabal A, et al. Multiple lymphoid polyposis and familial polyposis of the colon: a genetic relationship. Dis Colon Rectum 1978;21:336-341.
57. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 2003;58:(Suppl 6)S3-S43.
58. Burt RW. Polyposis syndrome review. Clin Perspect Gastroenterol 2002;Jan/Feb:51-59.
59. Talbot IC, Burt R, Jarvin H, et al. Familial adenomatous polyposis. In Hamilton SR, Aaltonen LA, eds. WHO Classification of Tumors, Pathology, and Genetics: Tumors of the Digestive System. Lyon, France: IARC Press, 2000:120-125.
60. Hamilton SR, Vogelstein B, Kudo S, et al. Carcinoma of the colon and rectum. In Hamilton SR, Aaltonen LA, eds. WHO Classification of Tumors, Pathology, and Genetics: Tumors of the Digestive System. Lyon, France: IARC Press, 2000:105-119.
61. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th edition. New York, NY: Springer-Verlag, 2002:113-122.
62. Soetikno R, Friedland S, Caltenbach T, et al. Non-polypoid (flat and depressed) colorecal neoplasm. Gastroenterology 2006;130:566-576.
63. Minamoto T, Sawaguchi K, Ohta T, et al. Superficial type adenoma in adenocarcinoma of the colon and rectum: a comparative morphological study. Gastroenterology 1994;106:1436-1443.
64. Bond JH. Small flat adenomas appear to have little clinical importance in Western countries. Gastrointest Endosc 1995;42:184-186.
65. Saito HY, Wasman I, West AB, et al. Prevalence in distinctive biological features of flat colorectal adenomas in a North American population. Gastroenterology 2001;120:1657-1665.
66. Jaramillo E, Watanabe EM, Slezak P, et al. Flat neoplastic lesions of the colon and rectum detected by high resolution video endoscopy and chromoscopy. Gastrointest Endosc 1995;42:114-122.
67. Rembacken BJ, Fuji T, Cairns A, et al. Flat and depressed colonic neoplasms: a perspective study of one thousand colonoscopies in the UK. Lancet 2000;305:1211-1214.
68. Kudo S, Kashida H, Tamura T, et al. Colonoscopic diagnosis and management of nonpolypoid early colorectal cancer. World J Surg 2000;24:1081-1090.
69. Hurlstone DP, Sanders DS, Cross SS, et al. Colonoscopic resection of lateral spreading tumors: perspective analysis of endoscopic mucosal resection. Gut 2004;53:1334-1339.
70. Samowitz WS, Burt RL. The nonspecificity of histological findings reported for flat adenoma. Hum Pathol 1995;26:571-573.
71. Muto K, Kamiya J, Sawada T, et al. Small "flat adenoma" of the large bowel with special reference to its clinicopathological features. Dis Colon Rectum 1985;28:847-851.
72. Adechi M, Muto T, Okinaga K, et al. Clinicopathological features of the flat adenoma. Dis Colon Rectum 1991;34:981-986.
73. Uno Y, Munakata A, Tanaka M. The discrepancy of histological diagnosis between flat early colon cancers and flat adenomas. Gastrointest Endosc 1994;40:1-6.
74. Schlemper RJ, Itabashi M, Kato Y, et al. Differences in a diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer 1998;82:60-69.
75. Hiraoka S, Kato J, Tatsukawa M, et al. Lateral spreading type of colorectal adenoma exhibits a unique methylation phenotype in K-ras mutation. Gastroenterology 2006;131:379-389.
76. Lauwers GY, Band S, Mino M, et al. Endoscopic mucosal resection for gastric epithelial neoplasms. A study of 39 cases with emphasis on the evaluation of specimens and recommendations for optimal pathology analysis. Mod Pathol 2004;17:2-8.
77. Lieberman DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007;133:1077-1085.
78. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopic surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006;130:1872-1885.
79. Lewin MR, Fenton H, Burkart AL, et al. Poorly differentiated colorectal carcinoma with invasion restricted to lamina propria (intramucosal carcinoma): a follow-up study of 15 cases. Am J Surg Pathol 2007;31:1882-1886.
80. Cooper HS, Deppisch LM, Kahn EL, et al. Pathology of the malignant colorectal polyp. Hum Pathol 1998;29:15-26.
81. Uneo H, Mochizuki H, Hashiguchi Y, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004;127:385-394.
82. Cooper HS, Deppisch LM, Gourley WK, et al. Endoscopically removed malignant colorectal polyps: clinicopathological correlations. Gastroenterology 1995;108:1657-1665.
83. Morson BC, Whiteway JF, Jones EA, et al. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut 1985;25:437-444.
84. Volk EE, Goldblum JR, Petras RE, et al. Management and outcome of patients with invasive cancer arising in colorectal polyps. Gastroenterology 1995;109:1801-1807.
85. Cooper HS. Pathology of the endoscopically removed malignant colorectal polyp. Curr Diagn Pathol 2007;13:423-437.
86. Kaneko I, Tanaka S, Oka S, et al. Lymphatic vessel density at the site of deepest penetration as a predictor of lymph node metastasis in submucosal colorectal cancer. Dis Colon Rectum 2006;50:1-9.
87. Pascal RR, Hertzler G, Hunter S, et al. Pseudoinvasion with high grade dysplasia in a colonic adenoma: distinction from adenocarcinoma. Am J Surg Pathol 1990;14:694-607.
88. Qirschmid K, Kiesler J, Mathis G, et al. Epithelial misplacement after biopsy of colorectal adenomas. Am J Surg Pathol 1993;17:1262-1265.
89. Jo W-S, Chung DC. Genetics of hereditary colorectal cancer. Semin Oncol 2005;32:11-23.
90. Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003;348:791-799.
91. DiGregorio C, Frattini M, Maffei S, et al. Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis. Gastroenterology 2006;131:439-444.
92. Southey MC, Young MA, Whitty J, et al. Molecular pathological analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying pathogenesis. Am J Surg Pathol2001;25:936-941.
93. Ponti G, DeLeon MP. Muir-Torre syndrome. Lancet Oncol 2005;6:980-987.
94. Whitelaw SC, Murday VA, Tomlinson IP, et al. Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology 1997;112:327-334.
95. Weiss NS, Yang GP. Incidence of histologic types of cancer of the small intestine. J Natl Cancer Inst 1987;78:653-656.
96. Dukes CE, Bussey HJ. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958;12:309-320.
97. Compton CC, Fleming LP, Burgart LG, et al. Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:979-994.
98. Jass JR, O'Brien MJ, Riddell RH, et al. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Human Pathol 2007;38:537-545.
99. Hase K, Shatney C, Johnson D, et al. Prognostic value of tumor budding in patients with colorectal cancer. Dis Colon Rectum 1993;36:627-635.
100. Goldstein NS, Hart J. Histological features associated with lymph node metastasis in stage T2 and superficial T2 rectal adenocarcinoma in abdominoperineal resection specimens. Am J Clin Pathol 1999;111:51-58.
101. Sasaki O, Atkin WS, Jass JR. Mucinous carcinoma of the rectum. Histopathology 1987;11:259-272.
102. Wu CS, Tong SY, Chen PC, et al. Clinicopathological study of colorectal mucinous carcinoma in Taiwan: a multivariate analysis. J Gastroenterol Hepatol 1996;11:77-81.
103. Messerini L, Ciantelli M, Baglioni S, et al. Prognostic significance of microsatellite instability in sporadic mucinous colorectal cancers. Hum Pathol 1999;30:629-634.
104. Bernick PE, Klimstra DS, Shia J, et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum 2004;47:163-169.
105. Gibbs NM. Undifferentiated carcinoma of the large intestine. Histopathology 1977;1:77-84.
106. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological molecular features. Histopathology 2007;50:113-130.
107. Jessurun J, Romero-Guadarama R, Manivel JC. Medullary adenocarcinoma of the colon: clinical pathological study of eleven cases. Hum Pathol 1999;30:843-848.
108. Ruschoff J, Dietmaier W, Luttges J, et al. Poorly differentiated colonic adenocarcinoma medullary type. Am J Pathol 1997;150:1815-1825.
109. Hino IT, Tani M, Lucas PC, et al. Loss of CDX2 expression in microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol 2001;159:2239-2248.
110. Lanza G, Gafa R, Matteuzzi M, et al. Medullary type poorly differentiated adenocarcinoma of the large bowel: distinct clinical pathological entity characterized by microsatellite instability and improved survival. J Clin Oncol 1999;17:2429-2438.
111. Smyrk TC. Colon cancer connections: cancer syndrome meets molecular biology meets histopathology. Am J Pathol 1994;145:1-6.
112. McGregor DK, Wu T-T, Rashid A, et al. Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability. Am J Surg Pathol 2004;28:712-718.
113. Comer TP, Beahrs OH, Dockerty MD. Primary squamous cell carcinoma and adenoacanthoma of the colon. Cancer 1971;28:1111-1117.
114. Makinen MJ. Colorectal serrated adenocarcinoma. Histopathology 2007;50:131-150.
115. Hubt B, Roj E, Schwartz MR, et al. Colorectal adenocarcinoma with micropapillary pattern and its association with lymph node metastasis. Mod Pathol 2007;20:729-733.
116. Kim MJ, Hong S-M, Jang SJ, et al. Invasive colorectal micropapillary carcinoma. An aggressive variant of adenocarcinoma. Hum Pathol 2006;37:809-815.
117. Parall F. Tumor budding in colorectal carcinoma. Histopathology 2007;50:151-162.
118. Engstrom PF, Arnoletti JP, Benson AB III, et al. Rectal cancer. J Natl Compr Canc Netw 2007;5:940-981.
119. Rodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-8696.
120. Vecchio FM, Valentini V, Minsky B, et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005;62:752-776.
121. Shia J, Guillem JG, Moore HG, et al. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol 2004;28:215-223.
122. Rullier A, Laurent C, Vendrely V, et al. Impact of colloid response and survival after preoperative radiotherapy and locally advanced rectal carcinoma. Am J Surg Pathol 2005;29:602-606.
123. Baxter NN, Morris AM, Rothenberger DA, et al. Impact of pre-operative radiation for rectal cancer on subsequent lymph node evaluation: a population based analysis. Int J Radiat Oncol Biol Phys 2005;61:426-431.
124. Nicastri DG, Duchette JT, Godfrey TE, et al. Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn 2007;9:563-571.
125. Weidner N, Zekan P. Carcinosarcoma of the colon: report of a unique case with light and immunohistochemical studies. Cancer 1986;58:1126-1130.
126. Hainsworty JD, Greco TA. Human chorionic gonadotropin production by colon cancer. Cancer 1985;56:1337-1340.
127. Nakqyama H, Akikusa B, Kondo Y, et al. Mucinous cystadenocarcinoma of the colon: report of a case. Dis Colon Rectum 1989;32:243-246.
128. Rubio CA. Clear cell adenocarcinoma of the colon. J Clin Pathol 1995;48:1142-1144.
129. Ishikura H, Kishimoto T, Andachi H, et al. Gastrointestinal hepatoid adenocarcinoma, venous permeation and mimicry of hepatocellular carcinoma: a report of four cases. Histopathology 1997;31:47-54.
130. Tada S, Iida M, Matsumoto Y, et al. Small flat cancer of the rectum: clinicopathological and endoscopic features. Gastrointest Endosc 1995;42:109-113.
131. Stolte M, Bethke B. Colorectal mini de novo carcinoma: a reality in Germany too. Endoscopy 1995;27:286-290.
132. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-1981.
133. Samowitz WS, Albertsen H, Herrick J, et al. Evaluation of a large population based sample support: CpG methylator phenotype in colon cancer. Gastroenterology 2005;129:837-845.
134. Goel A, Nagasaka T, Arnold CN, et al. CpG island methylated phenotype and chromosome instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 2007;132:127-138.
135. Chirieac LR, Shen L, Catarano PJ, et al. Phenotype of microsatellite stable colorectal carcinomas with CpG island methylation. Am J Surg Pathol 2005;29:429-436.
136. Wheeler JM, Boder WF, McMortensen NJ. DNA mismatch repair genes in colorectal cancer. Gut 2000;47:148-153.
137. Boland CR, Thibodeao SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection in familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257.
138. Johnson V, Vilikos E, Halford SE, et al. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome. Gut 2005;54:264-267.
139. Lanza G, Gafa R, Santini A, et al. Immunohistochemical tests for MLH-1 and MLH-2 expression predicts clinical outcome in stage II and stage III colorectal cancer patients. J Clin Oncol 2006;24:2359-2367.
140. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome in microsatellite instability). J Natl Cancer Inst 2004;96:261-268.
141. Chirieac LR, Shen L, Catallano PJ, et al. Phenotype of microsatellite stable colorectal carcinomas with CpG island methylation. Am J Surg Pathol 2005;29:429-436.
142. Wright CM, Dent OF, Newland RC, et al. Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal cancer. Gut 2005;54:103-108.
143. Smyrk TC, Watson P, Kaul K, et al. Tumor infiltrating lymphocytes are a marker for microsatellite instability in colorectal cancer. Cancer 2001;91:2417-2422.
144. Jenkins MA, Hayshai S, O'shea A-M, et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 2007;133:48-56.
145. Shia J, Ellis NA, Paty PB, et al. The value of histopathology in predicting microsatellite instability in hereditary non-polyposis, colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 2003;27:1407-1417.
146. Wright CL, Stewart ID. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas. Am J Surg Pathol 2003;27:1393-1406.
147. Parc R, Gueroult S, Mouria N, et al. Prognostic significance of microsatellite instability determined by immunohistochemical staining MSH-2 and MLH-1 in sporadic T-3 Mo colon cancer. Gut 2004;53:371-375.
148. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323-332.
149. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954;139:846-851.
150. Maughan NJ, Morris E, Forman D, et al. The validation of the Royal College of Pathologists colorectal cancer minimum database within a population. Br J Cancer 2007;97:1393-1398.
151. Gosens S, Marlene JEM, Van-Krieken JM, et al. Improvement of staging by combing tumor and treatment parameters: the value for prognostication in rectal cancer. Clin Gastrointest Hepatol 2007;5:997-1103.
152. Quirke P, Dixon MF, Durdey P, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Lancet 1986;2:996-998.
153. De Haas-Koch DF, Baeten GM, Jager JJ, et al. Prognostic significant of radial margins of clearance in rectal cancer. Br J Surg 1996;83:781-785.
154. Nagtegaal ID, Marjnen CA, Kranenbarg EK, et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal cancer: not one millimeter, but two millimeters is the limit. Am J Surg Pathol 2002;26:350-357.
155. Shepherd NA, Baxter KJ, Love SB. The prognostic importance of peritoneal involvement in colonic carcinoma: a prognostic evaluation. Gastroenterology 1997;112:1090-1102.
156. Ludeman L, Shepherd NA. Serosal involvement in gastrointestinal cancer: its assessment and significance. Histopathology 2005;47:123-131.
157. Tekkis PP, Smith JJ, Heriot AG, et al. A national study on lymph retrieval and resection. Resectional surgery for colorectal cancer. Dis Colon Rectum 2006;49:1-11.
158. Sarli L, Bader G, Iusco D, et al. Number of lymph nodes examined in prognosis of TNM stage II colorectal cancer. Eur J Cancer 2005;41:272-279.
159. Engstrom PF, Arnoletti JP, Benson AB, III, et al. Colon cancer. J Natl Compr Canc Netw 2007;5:884-925.
160. Johnson PM, Porter GA, Riccardi R, et al. Increasing lymph node count is independently associated with improved long term survival in stage IIIb and IIIc colon cancer. J Clin Oncol 2006;24:3570-3575.
161. Kim YM, Suhj H, Chah J, et al. Additional lymph node examination from entire submission of residual mesenteric tissue in colorectal cancer specimens may not add clinical and pathological relevance. Hum Pathol2007;38:762-767.
162. Hermanek P, Hutter RVP, Sobin LH, et al. Classification of isolated tumor cells and micrometastasis. Cancer 1999;86:2668-2673.
163. Messerini L, Cianchi F, Cortessini C, et al. Incidence in prognostic significance of occult tumor cells in lymph nodes from patients with stage II a colorectal carcinoma. Hum Pathol 2006;37:1259-1267.
164. Skibber JM. Local excision for rectal cancer. J Natl Compr Canc Netw 2005;3:531-539.
165. Watanabe T, Wu TT, Catalano PJ, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001;344:1196-1206.
166. Gryfe R, Kim H, Hsiehet K, et al. Tumor microsatellite instability and clinical outcome of young patients with colorectal cancer. N Engl J Med 2000;342:69-77.
167. Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003;349:247-257.
168. Popat S, Hubner R, Houlston RS. Systemic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005;23:609-618.
169. Kim GP, Colangelo LH, Wieand HS, et al. Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. J Clin Oncol 2007;25:767-772.
170. Jover R, Zapater P, Castells A, et al. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 2006;55:848-855.
171. Khambata-Ford S, Garrett CR, Merophol NJ, et al. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J Clin Oncol 2007;25:3230-3237.
172. Lievre A, Bachet JB, Le Corre D, et al. IRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 2006;66:3992-3995.
173. Barrier A, Boelle PY, Roser F, et al. Prognosis of stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol 2006;24:4685-4691.
174. Barrier A, Roser F, Boelle PY, et al. Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling. Oncogene 2007;26:264-268.
175. Johnston PG, Kay E, Black JM, et al. A genetic signature of relapse in stage III colorectal cancer derived from formalin fixed paraffin embedded tissue (FFPE) tissue using a unique disease specific colorectal array. J Clin Oncol 2006;24(Suppl; Abstr 3519):18S.
176. Dabbs DJ. Diagnostic Immunohistochemistry. New York, NY: Churchill Livingstone, 2002.
177. Chittal S, Al Saati T, Delsol G. Epithelial membrane antigen in hematolymphoid neoplasms: a review. Appl Immunohistochem 1997;5:203-215.
178. May EE, Perentes E. Anti-Leu 7 immunoreactivity with human tumors: its value in the diagnosis of prostate cancer. Histopathology 1987;11:295-304.
179. Appelman HD. Epithelial neoplasia of the appendix. In Norris HT, ed. Pathology of the Colon, Small Intestine, and Anus. 2nd edition. New York, NY: Churchill Livingstone, 1991:263-303.
180. Younes M, Katikaneni PR, Lechago J. Association between mucosal hyperplasia of the appendix and adenocarcinoma of the colon. Histopathology 1995;26:33-37.
181. Renshaw AA, Kish R, Gould EW. Sessile serrated adenoma is associated with acute appendicitis in patients 30 years or older. Am J Clin Pathol 2006;126:875-877.
182. Yantiss RK, Panczykowski A, Misdraji J, et al. A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix. Am J Surg Pathol 2007;31:1742- 1753.
183. Carr NJ, McCarthy WF, Sobin LH. Epithelial noncarcinoid tumors and tumor-like lesions of the appendix: a clinicopathological study of 184 patients with a multivariate analysis of prognostic factors. Cancer1995;75:757-68.
184. Misdraji J, Yantis RK, Graeme-Cook FM, et al. Appendiceal mucinous neoplasms. Clinical pathological analysis of 107 cases. Am J Surg Pathol 2003;27:1089-1103.
185. MacGillivary DC, Heaton RB, Rushin JM, et al. Distant metastasis from a carcinoid of the appendix less than 1 cm in size. Surgery 1992;111:466-471.
186. Moertel CG, Weiland LH, Nagorney DM, et al. Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med 1987;317:1699-1701.
187. Carr NJ, Sobin LH. Unusual tumors of the appendix and pseudomyxoma peritonei. Semin Diagn Pathol 1996;13:314-325.
188. Burke AP, Sobin LH, Federspiel BH, et al. Goblet cell carcinoid and related tumors of the vermiform appendix. Am J Clin Pathol 1990;94:27-35.
189. Park K, Blessing K, Kerr K, et al. Goblet cell carcinoid of the appendix. Gut 1990;31:322-324.
190. Kukle MH, Mayer RJ. Carcinoid tumors: medical progress. N Engl J Med 1999;340:858-868.
191. Lewin K. Carcinoid tumors and the mixed (composite)-glandular endocrine cell carcinomas. Am J Surg Pathol 1987;11:71-86.
192. Moyana TN, Qizilbash AH, Murphy F. Composite glandular and carcinoid tumors of the rectum. Am J Surg Pathol 1988;12:607-611.
193. Modlin IM, Kidd M, Latich I, et al. Current status of gastrointestinal carcinoids. Gastroenterology 2005;128:1717-1751.
194. Poultsides GA, Frederick WA. Carcinoid of the ampulla of Vater: morphologic features and clinical implications. World J Gastroenterol 2006;12:7058-7060.
195. Williams GT. Endocrine tumours of the gastrointestinal tract: selected topics. Histopathology 2007;50:30-41.
196. Burke AP, Sobin LH, Federspiel BH, et al. Carcinoid tumors of the duodenum: a clinicopathological study of 99 cases. Arch Pathol Lab Med 1990;114:700-704.
197. Koura AN, Giacco CG, Curley SA, et al. Carcinoid tumors of the rectum: effect of size, histopathology, and surgical treatment on metastases-free survival. Cancer 1997;79:1294-1298.
198. Soga J. Early stage carcinoids of the gastrointestinal tract. Analysis of 1914 reported cases. Cancer 2005;103:1587-1595.
199. Barbaraschi M, Roldo C, Zamboni G, et al. CDX-2 homeobox gene product expression in neuroendocrine tumors. Its role as a marker of intestinal neuroendocrine tumors. Am J Surg Pathol 2004;28:1169-1176.
200. Akintola-Ogunremi O, Pfeifer JD, Tan BR, et al. Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas. Am J Surg Pathol 2003;27:1551-1558.
201. Gurbuxani S, Anastasi J. What to do when you suspect gastrointestinal lymphoma: a pathologist's perspective. Clin Gastroenterol Hepatol 2007;5:417-421.
202. Gascoynar D, Muller-Hermelink HK, Chott A, et al. B cell lymphoma of the small intestine. In Hamilton SR, Aaltonen LA, eds. WHO Classification of Tumors, Pathology, and Genetics: Tumors of the Digestive System. Lyon, France: IARC Press, 2000:83-86.
203. Muller-Hermelink HK, Chott A, Coyne RD, et al. B cell lymphoma of the colon and rectum. In Hamilton SR, Aaltonen LA, eds. WHO Classification of Tumors, Pathology, and Genetics: Tumors of the Digestive System. Lyon, France: IARC Press, 2000:139-141.
204. Gascoynar D, Muller-Hermelink HK, Chott A, et al. Intestinal T cell lymphoma. In Hamilton SR, Aaltonen LA, eds. WHO Classification of Tumors, Pathology, and Genetics: Tumors of the Digestive System. Lyon, France: IARC Press, 2000:87-89.
205. Domizio P, Owen RA, Shepherd NA, et al. Primary lymphoma of the small intestine: a clinicopathological study of 119 cases. Am J Surg Pathol 1993;17:429-442.
206. Shepherd NA, Hall PA, Coates PJ, et al. Primary malignant lymphoma of the colon and rectum: a histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations. Histopathology1988;12:235-252.
207. Gilinsky NH, Novis BH, Wright JP, et al. Immunoproliferative small intestinal disease: clinical features and outcome in 20 cases. Medicine (Baltimore) 1987;66:438-446.
208. Almasri NM, Al-Abbadi M, Rewaily E, et al. Primary gastrointestinal lymphomas in Jordan are similar to those in Western countries. Mod Pathol 1997;10:137-141.
209. Zettl A, de Leeuw R, Haralambieva E, et al. Enteropathy type T-cell lymphoma. Am J ClinPathol 2007;127:701-706.
210. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;85:1361-1392.
211. Moynihan MJ, Bast MA, Chan WC, et al. Lymphomatous polyposis: a neoplasm of either follicular mantel or germinal center origin. Am J Surg Pathol 1996;20:442-452.
212. Watabe Y, Nakamuri S, Nakamuri T, et al. Multiple polypoid lesions of primary mucosal associated lymphoid tissue lymphoma of colon. Histopathology 1998;32:116-125.
213. Le Brun DP, Kamel OW, Cleary ML, et al. Follicular lymphomas of the gastrointestinal tract: pathological features in 31 cases and bcl-2 oncogenic protein expression. Am J Pathol 1992;140:1327-1335.
214. Hirakawa K, Fuchigomi T, Nakamura S, et al. Primary gastrointestinal T cell lymphoma resembling multiple lymphomatous polyposis. Gastroenterology 1996;111:778-782.
215. Banks PM. Gastrointestinal lymphoproliferative disorders. Histopathology 2007;50:42-54.
216. Shia J, Teruya-Feldstein J, Pan D, et al. Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathological study of twenty-six cases. Am J Surg Pathol 2002;26:216-224.
217. Yshino T, Mayake K, Ichimura K, et al. Increased incidence of follicular lymphoma in the duodenum. Am J Surg Pathol 2000;24:688-693.
218. Hsiao CH, Lee WI, Chang SL, et al. Angiocentric T cell lymphoma of the intestine: a distinct etiology of ischemic bowel disease. Gastroenterology 1996;110:985-990.
219. Weiss RC, Lazarus KH, Macon WR, et al. Natural killer like T-cell lymphoma in the small intestine of a child without evidence of enteropathy. Am J Surg Pathol 1997;21:964-969.
220. Longacre TA, Listrom MB, Spigel JH, et al. Aggressive jejunal lymphoma of large granular lymphocytes. Am J Clin Pathol 1990;93:124-132.
221. Medeiros F, Corless CL, Duensing A, et al. Kit-negative gastrointestinal stromal tumor. Proof of concept at therapeutic implication. Am J Surg Pathol 2000;28:889-894.
222. Miettenen M, Losot A. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006;23:70-83.
223. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors. A consensus approach. Hum Pathol 2002;33:459-465.
224. Alobei DB, Brooks JJ, Zhang PJ. Aberrant cytokeratin subset immunoreactivity in sarcomas using a large panel of cytokeratin subset. Appl Immunohistochem 1998;6:154-157.
225. Corles CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol 2004;22:3813-3825.
226. Hornick JL, Fletcher CD. The role of KIT in the management of patients with gastrointestinal stromal tumors. Hum Pathol 2007;38:679-687.
227. Miettinen M, Losata J. Kit (CD-117): review on expression in normal and neoplastic tissues, and mutations and their clinical pathological correlations. Immunohistochem Mol Morphol 2005;13:205-220.
228. Lucas DR, Al-Abbadi M, Tabaczka P, et al. C-kit expression and desmoid fibromatosis comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol 2003;119:339-345.
229. Miettinen M, El-Ritari W, Sobin LH, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 2002;33:478-483.
230. Herrera GA, Cevezo L, Jones JE, et al. Gastrointestinal autonomic nerve tumors: plexosarcomas. Arch Pathol Lab Med 1989;113:846-853.
231. Lauwers GY, Erlandson RA, Casper ES, et al. Gastrointestinal autonomic nerve tumors: a clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol 1993;17:887-897.
232. Lee JR, Joshi V, Griffin JW, Jr., et al. Gastrointestinal autonomic nerve tumor: immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol 2001;25:979-987.
233. Miettinen M, Furlong M, Sarlomo-Rakal AM, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinical pathological immunohistochemical molecular genetic study of one hundred and forty-four cases. Am J Surg Pathol 2001;25:1121-1133.
234. Miettinen M, Sarloma-Rakala M, Sobin LH, et al. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinical pathological, immunohistochemical molecular genetic study of forty-four cases. Am J Surg Pathol 2000;24:1339-1352.
235. Miettinen M, Shekit KM, Sobin LH. Schwannomas in the colon and rectum: a clinicopathological and immunohistochemical study of twenty cases. Am J Surg Pathol 2001;25:846-855.
236. Groisman GM, Polak-Ciarcon S, Appelman HD. Fibroblastic polyp of the colon: clinicopathological analysis of 10 cases with emphasis on its common association with serrated crypts. Histopathology 2006;48:431-437.
237. Eslami-Varzaneh F, Washington K, Robert ME, et al. Benign fibroblastic polyps of the colon. A histologic, immunohistochemical, and ultrastructural study. Am J Surg Pathol 2004;28:374-378.
238. Hornick JL, Fletcher CDM. Intestinal perineuriomas. Clinicopathologic definition of a new anatomic subset in a series of 10 cases. Am J Surg Pathol 2005;29:859-865.
239. Leibman SL, Wright TL, Altman DF. Gastrointestinal Kaposi's sarcoma in patients with acquired immunodeficiency syndrome: endoscopic and autopsy study. Gastroenterology 1965;89:102-108.
240. Yao T, Nagai E, Utsunomiya T, et al. An intestinal counterpart of pyogenic granuloma of the skin: a newly proposed entity. Am J Surg Pathol 1995;19:1054-1060.
241. Makhlouf HR, Sobin LH. Inflammatory myofibroblastic tumors (inflammatory pseudotumors) of the gastrointestinal tract: how closely are they related to inflammatory fibroid polyp. Hum Pathol 2002;33:307-315.
242. Bavikatty NR, Goldblum JR, Abdul-Krimf W, et al. Florid vascular proliferation of the colon related to intussusception in mucosal prolapse: potential diagnostic confusion with angiosarcoma. Mod Pathol 2001;14:1114-1118.
243. Scheithauer BW, Nora FE, Lechago J, et al. Duodenal gangliocytic paraganglioma: clinicopathologic and immunohistochemical study of 11 cases. Am J Clin Pathol 1986;86:559-565.
244. Dookhan DB, Miettinen M, Finkel G, et al. Recurrent duodenal gangliocytic paraganglioma with lymph node metastases. Histopathology 1993;22:399-401.
245. Witkiewicz A, Galler A, Yeo CJ, et al. Gangliocytic paraganglioma: case report and review of the literature. J Gastrointest Surg 2007;11:1351-1354.
246. Hornick JL, Fletcher CDM. PEComa: what do we know so far? Histopathology 2006;48:75-82.
247. Murray SK, Breau RH, Guha AK, et al. Spread of prostate carcinoma to the perirectal lymph node basin. Am J Surg Pathol 2004;28:1154-1162.
248. Yantis RK, Clement BP, Young RH. Neoplastic and pre-neoplastic changes in gastrointestinal endometriosis. Am J Surg Pathol 2000;24:513-524.
249. Park SY, Kim HS, Hong EK, et al. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol 2002;33:1078-1085.